SVRA – savara, inc. (US:NASDAQ)
Stock Stats
News
Savara to Present at the Citizens JMP Life Sciences Conference
Savara Inc (NASDAQ: SVRA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $8.00 price target on the stock.
Savara Inc (NASDAQ: SVRA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $8.00 price target on the stock.
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024 [Yahoo! Finance]
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
Form ARS Savara Inc For: Dec 31
Form DEFA14A Savara Inc
Form DEF 14A Savara Inc For: Jun 06
Form 4 Savara Inc For: Apr 21 Filed by: Erickson Anne
Form SC 13D/A Savara Inc Filed by: Bain Capital Life Sciences Fund II, L.P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.